You just read:

Oncolytics Biotech® Inc. Reports Updated Data from Randomized Phase 2 Study of REOLYSIN® in Pancreatic Cancer

News provided by

Oncolytics Biotech Inc.

14 Apr, 2016, 06:30 ET